GlassScriptPhysician profile
Claudia Arrigg
NPI 1093793564
$3,190.59
in general payments reported to CMS, 2019-2025
19 companies · $840 in 2025
The $840 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $219 · 2021: $439 · 2022: $426 · 2023: $521 · 2024: $548 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $924.13 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Allergan, INC. | $374.51 | 2019-2021 | |
| Alcon Vision LLC | $366.82 | 2021-2025 | Hydrus Microstent, Voyager Dslt, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $333.55 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $260.37 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $194.87 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $145.02 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $99.02 | 2019-2023 | |
| Oyster Point Pharma, INC. | $76.77 | 2023-2024 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $74.19 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $53.50 | 2025 | Purified Cortrophin Gel |
| Glaukos Corporation | $35.66 | 2023 | |
| Astellas Pharma US INC | $31.78 | 2025 | Izervay |
| Akorn, INC. | $26.91 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $22.04 | 2024 | Syfovre |
| Amgen INC. | $21.58 | 2024 | Tepezza |
| Thea Pharma INC. | $18.56 | 2025 | Iyuzeh |
| Regeneron Healthcare Solutions, INC. | $13.24 | 2024 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Arrigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.